| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 3 securities · may seek to influence control | ||||||
|
Global Business Travel Group, Inc.
13D/A
GBTG · 37890B100
|
0% |
9/29/2026
Event 9/29/2026
|
||||
| West Bay BDC LLC 13D/A | 97.1% |
7/29/2026
Event 7/27/2026
|
||||
| 5C Lending Partners Corp. 13D | 17.7% |
5/13/2026
Event 3/20/2026
|
||||
| Schedule 13G · 10 securities · passive | ||||||
|
Aspen Neuroscience, Inc.
13G
044933109
|
6.7% |
11/3/2026
Event 10/30/2026
|
||||
|
Nanobiotix SA
13G/A
NBTX · 63009J107
|
7.0% |
7/29/2026
Event 6/30/2026
|
||||
|
Fluence Energy, Inc.
13G/A
FLNC · 34379V103
|
8.3% |
5/19/2026
Event 5/15/2026
|
||||
|
Sionna Therapeutics Inc
13G/A
SION · 829401108
|
4.5% |
5/12/2026
Event 3/31/2026
|
||||
| Qatar Investment Authority | 4.5% | |||||
| Q Healthcare Holding LLC | 4.5% | |||||
|
BioXcel Therapeutics, Inc.
13G/A
BTAI · 09075P105
|
0.6% |
3/30/2026
Event 12/31/2025
|
||||
|
Perspective Therapeutics Inc
13G
CATX · 46489V302
|
6.2% |
2/5/2026
Event 2/4/2026
|
||||
|
Alignment Healthcare, Inc.
13G
ALHC · 01625V104
|
6.7% |
9/24/2025
Event 9/17/2025
|
||||
| Qatar Investment Authority | 6.7% | |||||
| Q Healthcare Holding LLC | 6.7% | |||||
|
Vistra Corp
13G
VST · 92840M102
|
5.5% |
8/5/2025
Event 6/30/2025
|
||||
| Qatar Investment Authority | 5.5% | |||||
| Seismic Holding LLC | 5.5% | |||||
|
Establishment Labs Holdings Inc
13G/A
ESTA · G31249108
|
8.3% |
5/13/2025
Event 3/31/2025
|
||||
|
Lomond Therapeutics Holdings, Inc.
13G
54173L101
|
7.8% |
3/26/2025
Event 3/24/2025
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.